Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare U.S., LLC, Cranbury, NJ 08512, NDC 43547-331-09.

D-1049-2016

May 30, 2016

Class III

Product summary

Firm
Prinston Pharmaceutical Inc
Event
Event 74423
Status
Terminated
Classification
Class III
Quantity
60 bottles (5 cases)
Official record key
drug-enforcement:D-1049-2016

Official wording

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.

Code information: Lot #: 327B16002, Exp 12/17

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect or Missing